Xcout Intel
Broadwing Bio
Broadwing Bio is a biotechnology company that develops antibody-based therapies to treat major causes of adult vision loss, specifically focusing on Geographic Atrophy and Glaucoma. The company utilizes genetics-driven insights to target ocular diseases and preserve vision for patients.
Subscribe to see Broadwing Bio’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Broadwing Bio at a glance
Broadwing Bio is a biotechnology company. Its most recent funding round, Convertible Debt, raised $10M in December 2020. Xcout tracks 5 named people at Broadwing Bio, including Andrew Peterson (Founder, CEO and board member).
Broadwing Bio leadership
- Andrew PetersonFounder, CEO and board member
- Jennifer CyganFounder
- Manuel RivasFounder and scientific advisory board member
- Errik AndersonBoard member and CEO of Alloy Therapeutics
- Atul DandekarBroadwing board member and chief strategy officer at Maze Therapeutics
Broadwing Bio funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Convertible Debt | $10M | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Broadwing Bio competitors
A few of Broadwing Bio's closest competitors — see the full list of competitors and alternatives →
Character Biosciences is a biotechnology company that uses human genetics and functional genomics to discover and develop precision medicines. Its work has focused particularly on genetically informed therapies for age-related diseases, including ophthalmic conditions such as age-related macular degeneration.
Beacon Therapeutics is a clinical-stage biotechnology company dedicated to saving and restoring sight for people living with rare and prevalent ocular diseases. The company works to deliver advanced retinal gene therapies to patients experiencing blindness.
Graybug Vision, Inc. is a clinical-stage biopharmaceutical company headquartered in Redwood City, California, with additional offices in Baltimore, Maryland, focused on developing medicines for ocular diseases.
Tavo Biotherapeutics is a biotechnology company headquartered in Laguna Beach, California. The company focuses on driving breakthrough pharmaceutical innovations and developing novel treatments for glaucoma and vision preservation.
SparingVision is a genomic and gene therapy medicines company translating pioneering science into vision-saving treatments, with US headquarters located in Boston, Massachusetts.
Alkeus Pharmaceuticals, Inc. is a late-stage biopharmaceutical company based in Cambridge, Massachusetts, dedicated to developing treatments that preserve the sight of individuals impacted by severe eye diseases.
Get Broadwing Bio's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Broadwing Bio in Xcout Intel
- 5 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access